BioCentury
ARTICLE | Finance

Tmunity’s A team

How Tmunity’s all-star team attracted unconventional investors

January 26, 2018 11:24 PM UTC

An all-star team with a proven track record in cell therapy enabled Tmunity Therapeutics Inc. to raise a $100 million series A round that included opportunistic investments from non-profits Be the Match BioTherapies and Parker Institute for Cancer Immunotherapy.

Fellow new investors Ping An Ventures and Gilead Sciences Inc. (NASDAQ:GILD) contributed, as did existing investors University of Pennsylvania and Lilly Asia Ventures...